Ranbaxy Nigeria, a leading name in Nigeria pharmaceutical sector recently introduced their 1st NCE. Arterolane maleate 150mg and piperaqunie phosphate 750mg. SYNRIAM. 1st of it's kind.

This drug will ensure

-Better Patient compliance due to OD dosage convenience and Reduced Pill Burden(I.e 1 tab. Daily)

-Food independent dosing

-High cure rates of 99.25% ACPR meeting WHO requirement of at least 95% ACPR

-Rapid onset of action

-Complete parasite clearance

-Faster relief of malarial symptoms (Fever, Chills etc.) as Fever Clearance time of Synriam is 6 Hrs compared to Artemether + Lumefantrine combination, which is 12 Hrs.

This product I belive will tackle the growing incedence of resistance to Artemether + Lumefantrine combination by P. falciparum. And reduce hospitalization due to malaria.

As we all aWait the outcome of the vaccine as promised by the non-tiring scientists the world over.

Source.
http://www.vanguardngr.com/2015/02/ranbaxy-tackles-malaria-novel-drug/


http://allafrica.com/stories/201502180378.html